Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kotaro Shide

Showing results (1-10 of 65) with videos related to

Pageof 7
Sort By:
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 12, 2018
[Pathogenesis of myeloproliferative neoplasms: insights from mouse models]Kotaro Shide
International Journal of Hematology|December 23, 2019
The role of driver mutations in myeloproliferative neoplasms: insights from mouse modelsKotaro Shide
International Review of Cell and Molecular Biology|November 10, 2021
Calreticulin mutations in myeloproliferative neoplasmsKotaro Shide
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|March 14, 2015
[Molecularly pathogenesis and molecular targeted therapy for myeloproliferative neoplasms]Kotaro Shide
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|July 13, 2022
[New aspects of myeloproliferative neoplasms: COVID-19 and myeloproliferative neoplasms]Kotaro Shide
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|August 11, 2015
[Genetic and epigenetic abnormalities in myeloproliferative neoplasms]Takuro Kameda, Kotaro Shide, Kazuya Shimoda
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|August 11, 2015
[Functional analysis of TET2 using a knockdown mouse model]Kotaro Shide, Takuro Kameda, Kazuya Shimoda
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|July 6, 2018
[Myeloproliferative neoplasms: recent progresses in therapy]Ayako Kamiunten, Kotaro Shide, Kazuya Shimoda
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|September 9, 2015
[Approach to special issues associated with myeloproliferative neoplasms]Takuro Kameda, Kotaro Shide, Yoko Kubuki
Biochemical and Biophysical Research Communications|August 24, 2010
Tyrosine kinase 2 interacts with the proapoptotic protein Siva-1 and augments its apoptotic functionsHaruko K Shimoda, Kotaro Shide, Takuro Kameda, et al.
Pageof 7

Showing results (1-10 of 65) with videos related to

Sort By:
Pageof 7
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 12, 2018
[Pathogenesis of myeloproliferative neoplasms: insights from mouse models]Kotaro Shide
International Journal of Hematology|December 23, 2019
The role of driver mutations in myeloproliferative neoplasms: insights from mouse modelsKotaro Shide
International Review of Cell and Molecular Biology|November 10, 2021
Calreticulin mutations in myeloproliferative neoplasmsKotaro Shide
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|March 14, 2015
[Molecularly pathogenesis and molecular targeted therapy for myeloproliferative neoplasms]Kotaro Shide
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|July 13, 2022
[New aspects of myeloproliferative neoplasms: COVID-19 and myeloproliferative neoplasms]Kotaro Shide
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|August 11, 2015
[Genetic and epigenetic abnormalities in myeloproliferative neoplasms]Takuro Kameda, Kotaro Shide, Kazuya Shimoda
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|August 11, 2015
[Functional analysis of TET2 using a knockdown mouse model]Kotaro Shide, Takuro Kameda, Kazuya Shimoda
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|July 6, 2018
[Myeloproliferative neoplasms: recent progresses in therapy]Ayako Kamiunten, Kotaro Shide, Kazuya Shimoda
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|September 9, 2015
[Approach to special issues associated with myeloproliferative neoplasms]Takuro Kameda, Kotaro Shide, Yoko Kubuki
Biochemical and Biophysical Research Communications|August 24, 2010
Tyrosine kinase 2 interacts with the proapoptotic protein Siva-1 and augments its apoptotic functionsHaruko K Shimoda, Kotaro Shide, Takuro Kameda, et al.
Pageof 7